37
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Optical gas imaging of carbon dioxide at tracheal extubation: a novel technique for visualising exhaled breath

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Editor - There is strong evidence that the dominant route of spread of SARS-CoV-19 is the airborne route and that the disease can be spread by both pre-symptomatic, symptomatic and asymptomatic people.(1, 2) The virus is carried in particles of various sizes that can travel considerable distances and remain suspended in the air.(3) Viral particles are released by all expiratory events (coughing, talking and exhalation) and do not require an aerosol-generating procedure to be detectable in the local environment.(3, 4). In the setting of extubation of the trachea, neither the distribution of exhaled gases or the capacity of these gases to carry virus in the peri-extubation period has been fully quantified. As a consequence of the assumed risk of disease transmission to healthcare workers present at extubation there have been a multitude of barrier techniques proposed to reduce risk at this time, but the overwhelming majority have not been subject to any objective testing.(5) In the small number of studies where testing has occurred, the main focus was on intubation, not extubation, and static measurements of dye deposition (representative of large droplets) in simulated settings were used.(5a) This methodology does not lend itself to assessment of environmental dispersal of smaller particles. Particle counting technology identifies aerosol in predetermined fixed loci and may miss less intuitive areas of exhalate. This study was performed to improve knowledge of the patterns of distribution of exhalate at the time of extubation which is considered an aerosol-generating procedure and therefore a potential risk to healthcare workers.(6) Knowledge regarding distribution of exhalate and the effect of barrier technologies may inform policies and procedures and reduce risk. The intended focus of the study is the perioperative period as opposed to the intensive care unit. While viral loads in the lung parenchyma and pharynx are higher in symptomatic individuals, the disease can be transmitted by those who are pre-symptomatic and asymptomatic.(7, 8) This is of relevance to COVID-19 patients having intercurrent surgery and because screening tests used to risk stratify those coming for elective surgery are known to have false negative results.(9). Optical gas imaging delivers real-time visualisation of exhaled breath air currents via a thermal camera designed for detection of carbon dioxide (CO2) (Flir GF343, FLIR Systems Inc, City?, OR, USA). We report qualitative CO2 optical gas imaging from a series of three SARS-CoV-2 negative subjects undergoing extubation in an operating theatre environment and subsequent breathing with a surgical facemask. Institutional ethical approval was obtained. All subjects were American Society of Anesthesiologists physical status 1 or 2, and written informed consent was obtained prior to the observations. In Video Sequence 1 extubation was performed without use of plastic covering. Exhalation around a deflated endotracheal tube cuff led to a significant plume of unfiltered exhaled gases anteriorly to a distance of ∼ 100 cm. Correct post-extubation positioning of an anaesthetic mask effectively inhibited exhaled air currents from anterior projection from the patient’s mouth (Video Sequence 2). A simple plastic sheeting in place over the subject’s face was also sufficient to redirect exhaled breath away from the anaesthesiologist’s face as seen in Video Sequences 2 and 3. However following placement of a paper surgical facemask after extubation, exhaled breath was redirected superiorly over the forehead of the patient in the direction of the attending anaesthesiologist, to face height (Video Sequence 4). Minimal anterior displacement of exhaled air through the facemask was noted following surgical facemask placement (Video Sequences 2 and 4). In view of these findings which show that the extubator remains closely exposed to unfiltered exhalate at the time of tracheal extubation and that a surgical facemask can divert flow towards the extubator, it is clear that wearing of appropriate personal protective equipment remains imperative. Whether this redirection allows for complete filtration of exhaled aerosol to the facemask material warrants further study. Deploying this imaging technology for evaluation of other airway techniques with potential for extensive droplet dispersal is warranted.figure 1 Figure 1 Authors’ contributions BM: Image acquisition and enhancement, editing and final draft preparation. RC: Image acquisition, review of text for submission. CM: Concept, image acquisition, review and editing of text for submission. DB: Concept, initial draft of text and review of text for submission. Declaration of interest DB is a board member of the British Journal of Anaesthesia. The other authors declare no conflicts of interest.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: not found

          SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

          To the Editor: The 2019 novel coronavirus (SARS-CoV-2) epidemic, which was first reported in December 2019 in Wuhan, China, and has been declared a public health emergency of international concern by the World Health Organization, may progress to a pandemic associated with substantial morbidity and mortality. SARS-CoV-2 is genetically related to SARS-CoV, which caused a global epidemic with 8096 confirmed cases in more than 25 countries in 2002–2003. 1 The epidemic of SARS-CoV was successfully contained through public health interventions, including case detection and isolation. Transmission of SARS-CoV occurred mainly after days of illness 2 and was associated with modest viral loads in the respiratory tract early in the illness, with viral loads peaking approximately 10 days after symptom onset. 3 We monitored SARS-CoV-2 viral loads in upper respiratory specimens obtained from 18 patients (9 men and 9 women; median age, 59 years; range, 26 to 76) in Zhuhai, Guangdong, China, including 4 patients with secondary infections (1 of whom never had symptoms) within two family clusters (Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org). The patient who never had symptoms was a close contact of a patient with a known case and was therefore monitored. A total of 72 nasal swabs (sampled from the mid-turbinate and nasopharynx) (Figure 1A) and 72 throat swabs (Figure 1B) were analyzed, with 1 to 9 sequential samples obtained from each patient. Polyester flock swabs were used for all the patients. From January 7 through January 26, 2020, a total of 14 patients who had recently returned from Wuhan and had fever (≥37.3°C) received a diagnosis of Covid-19 (the illness caused by SARS-CoV-2) by means of reverse-transcriptase–polymerase-chain-reaction assay with primers and probes targeting the N and Orf1b genes of SARS-CoV-2; the assay was developed by the Chinese Center for Disease Control and Prevention. Samples were tested at the Guangdong Provincial Center for Disease Control and Prevention. Thirteen of 14 patients with imported cases had evidence of pneumonia on computed tomography (CT). None of them had visited the Huanan Seafood Wholesale Market in Wuhan within 14 days before symptom onset. Patients E, I, and P required admission to intensive care units, whereas the others had mild-to-moderate illness. Secondary infections were detected in close contacts of Patients E, I, and P. Patient E worked in Wuhan and visited his wife (Patient L), mother (Patient D), and a friend (Patient Z) in Zhuhai on January 17. Symptoms developed in Patients L and D on January 20 and January 22, respectively, with viral RNA detected in their nasal and throat swabs soon after symptom onset. Patient Z reported no clinical symptoms, but his nasal swabs (cycle threshold [Ct] values, 22 to 28) and throat swabs (Ct values, 30 to 32) tested positive on days 7, 10, and 11 after contact. A CT scan of Patient Z that was obtained on February 6 was unremarkable. Patients I and P lived in Wuhan and visited their daughter (Patient H) in Zhuhai on January 11 when their symptoms first developed. Fever developed in Patient H on January 17, with viral RNA detected in nasal and throat swabs on day 1 after symptom onset. We analyzed the viral load in nasal and throat swabs obtained from the 17 symptomatic patients in relation to day of onset of any symptoms (Figure 1C). Higher viral loads (inversely related to Ct value) were detected soon after symptom onset, with higher viral loads detected in the nose than in the throat. Our analysis suggests that the viral nucleic acid shedding pattern of patients infected with SARS-CoV-2 resembles that of patients with influenza 4 and appears different from that seen in patients infected with SARS-CoV. 3 The viral load that was detected in the asymptomatic patient was similar to that in the symptomatic patients, which suggests the transmission potential of asymptomatic or minimally symptomatic patients. These findings are in concordance with reports that transmission may occur early in the course of infection 5 and suggest that case detection and isolation may require strategies different from those required for the control of SARS-CoV. How SARS-CoV-2 viral load correlates with culturable virus needs to be determined. Identification of patients with few or no symptoms and with modest levels of detectable viral RNA in the oropharynx for at least 5 days suggests that we need better data to determine transmission dynamics and inform our screening practices.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Presumed Asymptomatic Carrier Transmission of COVID-19

            This study describes possible transmission of novel coronavirus disease 2019 (COVID-19) from an asymptomatic Wuhan resident to 5 family members in Anyang, a Chinese city in the neighboring province of Hubei.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure

              Background: Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on reverse transcriptase polymerase chain reaction (RT-PCR) are being used to “rule out” infection among high-risk persons, such as exposed inpatients and health care workers. It is critical to understand how the predictive value of the test varies with time from exposure and symptom onset to avoid being falsely reassured by negative test results. Objective: To estimate the false-negative rate by day since infection. Design: Literature review and pooled analysis. Setting: 7 previously published studies providing data on RT-PCR performance by time since symptom onset or SARS-CoV-2 exposure using samples from the upper respiratory tract (n = 1330). Patients: A mix of inpatients and outpatients with SARS-CoV-2 infection. Measurements: A Bayesian hierarchical model was fitted to estimate the false-negative rate by day since exposure and symptom onset. Results: Over the 4 days of infection before the typical time of symptom onset (day 5), the probability of a false-negative result in an infected person decreases from 100% (95% CI, 100% to 100%) on day 1 to 67% (CI, 27% to 94%) on day 4. On the day of symptom onset, the median false-negative rate was 38% (CI, 18% to 65%). This decreased to 20% (CI, 12% to 30%) on day 8 (3 days after symptom onset) then began to increase again, from 21% (CI, 13% to 31%) on day 9 to 66% (CI, 54% to 77%) on day 21. Limitation: Imprecise estimates due to heterogeneity in the design of studies on which results were based. Conclusion: Care must be taken in interpreting RT-PCR tests for SARS-CoV-2 infection—particularly early in the course of infection—when using these results as a basis for removing precautions intended to prevent onward transmission. If clinical suspicion is high, infection should not be ruled out on the basis of RT-PCR alone, and the clinical and epidemiologic situation should be carefully considered. Primary Funding Source: National Institute of Allergy and Infectious Diseases, Johns Hopkins Health System, and U.S. Centers for Disease Control and Prevention.
                Bookmark

                Author and article information

                Journal
                Br J Anaesth
                Br J Anaesth
                BJA: British Journal of Anaesthesia
                Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.
                0007-0912
                1471-6771
                25 November 2020
                25 November 2020
                Affiliations
                [1]The Rotunda Hospital, Dublin, Ireland
                Author notes
                []Corresponding author.
                Article
                S0007-0912(20)30936-3
                10.1016/j.bja.2020.11.016
                7687366
                33358042
                8604fb91-a227-4d32-a707-1cee40ec71a5
                © 2020 Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 26 October 2020
                : 11 November 2020
                : 12 November 2020
                Categories
                Correspondence

                Anesthesiology & Pain management
                aerosol-generating procedure,covid-19,optical gas imaging,sars-cov-19,tracheal extubation

                Comments

                Comment on this article